Topical Cycloheximide in Psoriasis
- 1 February 1976
- journal article
- research article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 3 (1) , 1-4
- https://doi.org/10.1111/j.1600-0560.1976.tb00840.x
Abstract
Cycloheximide is an antimitotic and an inhibitor of the synthesis of both DNA and protein. Topical application in low concentrations (0.1 %– 0.2 %) resulted in definite involution of psoriatic plaques. Because of its potency this experimental drug – not yet available for clinical use – was employed on small areas only and with extreme caution. Results of a full evaluation for safety, currently in progress, are being awaited with interest.This publication has 8 references indexed in Scilit:
- THE EFFECT OF ACTIDIONE ON MITOSIS IN THE SLIME MOLD PHYSARUM POLYCEPHALUM The Journal of cell biology, 1965
- Cycloheximide: Aspects of Inhibition of Protein Synthesis in Mammalian CellsScience, 1964
- Nucleic Acids in Normal and Pathological SkinDermatology, 1961
- A COMPARISON OF THE EFFECTS OF SEVERAL ANTIMITOTIC AGENTSJournal of Heredity, 1954
- USE OF A CYCLOHEXIMIDE MEDIUM FOR ISOLATION OF DERMATOPHYTES FROM CLINICAL MATERIALSArchives of Dermatology, 1953
- Chemotherapy of Experimental Chagas' Disease with Thirty AntibioticsThe American Journal of Tropical Medicine and Hygiene, 1953
- Control of Covered Smut of Wheat by Rapid Seed Treatment with an AntibioticScience, 1952
- ACTIDIONE, AN ANTIBIOTIC FROM STREPTOMYCES GRISEUSJournal of the American Chemical Society, 1947